News Releases 2010

RSS

21 DEC 2010 Pharmaceuticals
Starting co-promotion of the anti-cancer agent “SPRYCEL® Tablet 20mg and SPRYCEL® Tablet 50mg” (dasatinib) in Japan
17 DEC 2010 Pharmaceuticals
The results of a subset analysis of Japanese patients from the DASISION trial comparing SPRYCEL® (dasatinib) with imatinib in the treatment of newly diagnosed Philadelphia chromosome positive chronic myelogenous leukemia.
16 DEC 2010 Pharmaceuticals
Defendants Appeal From Final Judgment in U.S. Abilify® Patent Litigation
10 DEC 2010 Pharmaceuticals
World's First Aquaretic Agent for the Treatment of Volume Overload in Patients with Heart Failure Samsca® Tablets 15mg (tolvaptan), Vasopressin V2-Receptor Antagonist, to be Launched in Japan on December 14
9 DEC 2010 Corporate
Tokushima Itano Factory Recognized Among "Corporate Greening Linked to Conservation of Biodiversity: Best 100" Sole factory manufacturing medical-use pharmaceuticals to receive recognition
7 DEC 2010 Pharmaceuticals
Follow-Up Results from Study Comparing SPRYCEL® (dasatinib) to Imatinib in First-Line Treatment of Adults with Ph+ CP-CML Demonstrate Improved Response Rates Consistent with 12 Month Data
19 NOV 2010 Corporate
Toward a Factory that is Friendly to Both the Environment and People The Tokushima Itano Factory Helps to Support the Asan Earth Festival in Itano to be Held on November 23, 2010
18 NOV 2010 Pharmaceuticals
Otsuka Pharmaceutical Files Application in Japan for Additional Indication of L-Cartin® Tablets for Carnitine Deficiency, Based on Evidences in Public Domain
16 NOV 2010 Pharmaceuticals
Otsuka Prevails in U.S. Abilify® Patent Litigation

Go to the Top

Go to the Top

13 SEP 2010 Pharmaceuticals
The Antiplatelet Agent Pletaal® (Nonproprietary Name: Cilostazol) The Results of CSPS 2, a Large-Scale Clinical Trial of Cilostazol in Preventing Recurrent Strokes, Posted on the Online Version of The Lancet Neurology
8 SEP 2010 Nutraceuticals
Renewed Package Design for Nature Made America's number one-selling vitamin, mineral and supplement brand
1 SEP 2010 Corporate
Construction of 'OPS-5', New Plant to Manufacture Active Pharmaceutical Ingredients in Saga Factory Completed on September 1
31 AUG 2010 Corporate
Publication of Environmental and Social Report 2010 - Featuring approaches to help build a low-carbon, recycling-oriented society, development of environment-conscious products and social action programs -
16 AUG 2010 Corporate
21st Annual Outdoor Concert Held at Otsuka Pharmaceutical Tokushima Wajiki Factory Exciting Summer in Wajiki '10 on August 13, 2010
23 JUL 2010 Pharmaceuticals
E Keppra® (levetiracetam) receives regulatory approval in Japan
14 JUL 2010 Nutraceuticals
Care for delicate neck and decolletage areas InnerSignal Rejuvenate Clear-up Mask debuts September 1, 2010
12 JUL 2010 Pharmaceuticals
SPRYCEL® (dasatinib) Receives FDA Priority Review for the Treatment of Adult Patients with Newly Diagnosed Chronic Myeloid Leukemia (CML) in Chronic Phase
30 JUN 2010 Pharmaceuticals
GW and Otsuka Agree Three Year Extension to Global Cannabinoid Research Collaboration
14 JUN 2010 Pharmaceuticals
Otsuka receives approval for Rapirun® H. Pylori Antibody Stick as in vitro diagnostic device on June 8, 2010

Go to the Top

10 JUN 2010 Corporate
Otsuka Pharmaceutical Co., Ltd. Appoints the Board Members and Statutory Auditors (PDF:39KB)
9 JUN 2010 Pharmaceuticals
Four-Year Follow-Up Data for SPRYCEL® (dasatinib) Demonstrate 82 Percent Overall Survival in Patients with Chronic Myeloid Leukemia Who Failed Gleevec®
8 JUN 2010 Pharmaceuticals
SPRYCEL® (dasatinib) Demonstrates Superior Confirmed Complete Cytogenetic Response Rates Compared to Gleevec® in Study of Adult Patients with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase
7 JUN 2010 Pharmaceuticals
Otsuka Pharmaceutical to Introduce 1,300 iPad™ Units for Use as Multifunctional Pharmaceutical Information Tools
7 JUN 2010 Nutraceuticals
A new style of "thoughtful gesture" Pocari Sweat Heartfelt Summer Letter Available at Post Offices throughout Japan from June 15
31 MAY 2010 Pharmaceuticals
Streptococcus pneumoniae Kit "RAPIRUN Pneumococcus" Approval obtained as in vitro diagnostic on May 26
26 MAY 2010 Nutraceuticals
Indonesian affiliate PT. Amerta Indah Otsuka hosts May 26, 2010 dedication ceremony for Kejayan Factory - New Pocari Sweat production facility -
10 MAY 2010 Nutraceuticals
Nature MadeR Essential Nutrients for Modern Life Stlyes Introducing New Family Size Versions of Iron & Fish Oil(with EPA & DHA) Available from May 11, 2010
26 APR 2010 Pharmaceuticals
Core of Global Basic Research Drug Discovery Research Building "10th Research Center" Completed on April 26
23 APR 2010 Pharmaceuticals
First Antithrombotic Orally Disintegrating Tablets Antiplatelet Agent "Pletaal® OD Tablets" Launched on April 26

Go to the Top

23 APR 2010 Corporate
Otsuka Pharmaceutical to Exhibit Soylution Concept Video in Japan Industry Pavilion at Expo 2010 Shanghai
20 APR 2010 Nutraceuticals
A Refreshing New Concept: Whole Soy + Carbonate Sparkling Soy Water, SOYSH Debuts
8 APR 2010 Pharmaceuticals
Groundbreaking Ceremony for New Plant to Manufacture Active Pharmaceutical Ingredients held on April 8 at Saga Factory
31 MAR 2010 Corporate
First reader-participation collaboration OTSUKA Health Comic Library Sequel Vol. 3 “We Are Children of the Earth: The Environment & Our Health” March 31 publication for donation to elementary schools nationwide
17 MAR 2010 Pharmaceuticals
Otsuka Pharmaceutical and Acucela Receive FDA Fast Track Designation for ACU-4429 in Patients with Dry AMD
12 MAR 2010 Pharmaceuticals
FerriSeltz® powder 20%, MRI Oral GI Contrast Agent, Receives Additional Approval for GI Negative Imaging in Cholangiopancreatography
11 MAR 2010 Pharmaceuticals
Rapid Assay Kit for RS virus, QUICKNAVI-RSV, Launch on April 6
8 MAR 2010 Pharmaceuticals
In-vitro Diagnostic Kit, WT1 mRNA Assay Kit "Otsuka" Application Filed for Additional Purpose of Use with Myelodysplastic Syndromes
5 MAR 2010 Nutraceuticals
New Medicated Skin Wash from UL•OS Line of Men's Face & Body Care Available from April 22, 2010
1 MAR 2010 Pharmaceuticals
The Results of CSPS II, a Large-scale Clinical Trial of Cilostazol in Preventing Recurrent Strokes, Presented at American Stroke Association's International Stroke Conference on February 26

Go to the Top